Stazzone Peter has filed 3 insider transactions across 1 company since September 2025.
Most recent transaction: a grant/award of 50000 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. ($LIXT) on April 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 15, 2026 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Stazzone Peter | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 50,000.0000 | 6,171,195 | 9999.99% | 0.81% |
| April 15, 2026 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Stazzone Peter | Chief Financial Officer | D | Options to Purchase Common Stock | 50000 | $0.00 | 0.0000 | 6,171,195 | 100.00% | 0.81% |
| Sept. 1, 2025 | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $LIXT | Stazzone Peter | Chief Financial Officer | A | Options to Purchase Common Stock | 50000 | $0.00 | 50,000.0000 | 2,249,290 | 9999.99% | 2.22% |